Profoject Low Dead Space Syringe /Profoject Tuberculin Syringe; Profoject Low Dead Space Syringe with Needle /Profoject Tuberculin Syringe with Needle; Profoject Low Dead Space Syringe with Permanent Needle /Profoject Tuberculin Syringe with Permanent Needle; Profoject Low Dead Space Safety Syringe /Profoject Tuberculin Safety Syringe
CMT Health PTE., Ltd. · Decision date Feb 19, 2026
What did the FDA decide?
FDA records K252814 as a 510(k) premarket notification, with a decision dated Feb 19, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General Hospital
- Decision date
- Feb 19, 2026
Regulatory record facts
- Identifier
- K252814
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- CMT Health PTE., Ltd.
- Product code
- QNQ
- Decision code
- SESE
- Decision date
- Feb 19, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Low Dead Space Piston Syringe.
- Applicant
- CMT Health PTE., Ltd.
- Product code
- QNQ
- FDA device class
- 2
FDA decision timeline
K252814 received
Application receipt date recorded by FDA.
K252814 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
CMT Health PTE., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Singapore
Sources and methodology
- Original FDA record: K252814
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records